Uptake and use of a vaginal ring containing dapivirine for HIV-1 prevention in African women: an open-label extension study

BACKGROUND: Two Phase III clinical trials showed that use of a monthly vaginal ring containing 25 mg dapivirine was well-tolerated and reduced HIV-1 incidence in women by approximately 30% compared to placebo (3.3 and 4.1 versus 4.5 and 6.1 per 100 person-years). Understanding use of the dapivirine...

全面介紹

Na minha lista:
書目詳細資料
發表在:Lancet HIV
Main Authors: Baeten, Jared M., Palanee-Phillips, Thesla, Mgodi, Nyaradzo M., Mayo, Ashley J., Szydlo, Daniel W., Ramjee, Gita, Mirembe, Brenda Gati, Mhlanga, Felix, Hunidzarira, Portia, Mansoor, Leila E., Siva, Samantha, Govender, Vaneshree, Makanani, Bonus, Naidoo, Logashvari, Singh, Nishanta, Nair, Gonasagrie, Chinula, Lameck, Parikh, Urvi M., Mellors, John W., Balán, Iván C., Ngure, Kenneth, van der Straten, Ariane, Scheckter, Rachel, Garcia, Morgan, Peda, Melissa, Patterson, Karen, Livant, Edward, Bunge, Katherine, Singh, Devika, Jacobson, Cindy, Jiao, Yuqing, Hendrix, Craig W., Chirenje, Zvavahera M., Nakabiito, Clemensia, Taha, Taha E., Jones, Judith, Torjesen, Kristine, Nel, Annalene, Rosenberg, Zeda, Soto-Torres, Lydia E., Hillier, Sharon L., Brown, Elizabeth R.
格式: Artigo
語言:Inglês
出版: 2021
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8038210/
https://ncbi.nlm.nih.gov/pubmed/33539762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2352-3018(20)30304-0
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍